Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Cubicin (daptomycin) / Merck (MSD)

NCT01012089: Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease

Completed

N/A

Daptomycin, Cubicin

University of Oklahoma, Cubist Pharmaceuticals LLC

Chronic Kidney Disease, Bacterial Infection

04/14

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites